| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9880205 | Journal of the Neurological Sciences | 2005 | 9 Pages |
Abstract
Treatment with fasudil within 48 h of acute ischemic stroke onset significantly improved the patient's clinical outcome. This study found fasudil to be a useful and safe drug for patients with acute ischemic stroke. Further evaluations, for example, 3-month functional outcomes in a larger clinical trial, may help to define the efficacy of fasudil in acute ischemic stroke.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Masato Shibuya, Shunsaku Hirai, Minoru Seto, Shin-ichi Satoh, Eiichi Ohtomo, for the Fasudil Ischemic Stroke Study Group for the Fasudil Ischemic Stroke Study Group,